Add office photos
Employer?
Claim Account for FREE
Novartis
4.1
based on 1.6k Reviews
Company Overview
Associated Companies
Company Locations
Working at Novartis
Company Summary
Novartis operates in the global pharmaceuticals sector, focusing on innovative treatments and addressing critical healthcare challenges through advanced research.
Overall Rating
4.1/5
based on 1.6k reviews
5% above
industry average
Highly rated for
Work-life balance, Company culture, Salary
Critically rated for
Promotions
Work Policy
Hybrid
87% employees reported
Monday to Friday
76% employees reported
Flexible timing
89% employees reported
No travel
54% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
167 employees reported
Job/Soft skill training
165 employees reported
Office cab/shuttle
143 employees reported
Cafeteria
137 employees reported
View all benefits
About Novartis
Founded in1996 (29 yrs old)
India Employee Count5k-10k
Global Employee Count10k+
India HeadquartersMumbai, Maharashtra, India
Office Locations
Websitenovartis.com
Primary Industry
Other Industries
Are you managing Novartis's employer brand? To edit company information,
claim this page for free
Headquartered in Basel, Switzerland, we are a leading global medicines company. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We use innovative science and digital technologies to create transformative treatments in areas of great medical need.
In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. We also aim to reward those who invest their money, time, and ideas in our company.
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. Building trust with society with responsibility is a key pillar of the Novartis corporate strategy.
It defines our approach to managing our key Environment, Social, and Corporate Governance Goals (ESG) and corporate responsibility topics and risks: being part of the solution on pricing and access, addressing global health challenges, being a responsible citizen, and holding ourselves to high ethical standards. We have a long-standing commitment towards Zero Leprosy and Water Neutrality, amongst others.
In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. We also aim to reward those who invest their money, time, and ideas in our company.
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. Building trust with society with responsibility is a key pillar of the Novartis corporate strategy.
It defines our approach to managing our key Environment, Social, and Corporate Governance Goals (ESG) and corporate responsibility topics and risks: being part of the solution on pricing and access, addressing global health challenges, being a responsible citizen, and holding ourselves to high ethical standards. We have a long-standing commitment towards Zero Leprosy and Water Neutrality, amongst others.
Mission: Our mission is to discover new ways to improve and extend people’s lives.
Vision: Our vision is to be a trusted leader in changing the practice of medicine.
Managing your company's employer brand?
Claim this Company Page for FREE
Novartis Ratings
based on 1.6k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
805
4
416
3
171
2
67
1
123
Category Ratings
4.2
Work-life balance
4.1
Company culture
3.9
Salary
3.8
Job security
3.7
Skill development
3.7
Work satisfaction
3.3
Promotions
Novartis is rated 4.1 out of 5 stars on AmbitionBox, based on 1.6k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Novartis
based on 1.5k reviews
4.1
Rated by 377 Women
Rated 4.1 for Work-life balance and 4.1 for Company culture
4.1
Rated by 1.1k Men
Rated 4.2 for Work-life balance and 4.1 for Company culture
Work Policy at Novartis
based on 166 reviews in last 6 months
Hybrid
87%
Work from office
12%
Permanent work from home
1%
Novartis Reviews
Top mentions in Novartis Reviews
+ 5 more
Sopra Steria
Success to our employee's well-being? A work-life balance that's simply unbeatable.
Our employees have rated us 4 for Work-Life Balance on AmbitionBox
Compare Novartis with Similar Companies
|  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 1.6k reviews | 4.1/5 based on 1.8k reviews | 4.0/5 based on 5.8k reviews  | 4.1/5 based on 6.9k reviews |
Highly Rated for | Work-life balance Company culture Salary | Company culture Skill development Work-life balance | Salary Skill development Job security | Skill development Salary Work-life balance |
Critically Rated for | Promotions |  No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Hybrid 87% employees reported | Hybrid 70% employees reported | Work from office 82% employees reported | Work from office 73% employees reported |
Rating by Women Employees | 4.1 Good rated by 377 women | 4.1 Good rated by 277 women | 4.0 Good rated by 437 women | 4.1 Good rated by 682 women |
Rating by Men Employees | 4.1 Good rated by 1.1k men | 4.1 Good rated by 1.5k men | 4.0 Good rated by 5k men | 4.1 Good rated by 5.8k men |
Job security | 3.8 Good | 3.7 Good | 3.8 Good | 3.7 Good |
View more
Novartis Salaries
Novartis salaries have received with an average score of 3.9 out of 5 by 1.6k employees.
Senior Analyst
(403 salaries)
Unlock
₹8.5 L/yr - ₹24 L/yr
Analyst
(359 salaries)
Unlock
₹5.4 L/yr - ₹17.5 L/yr
Senior Financial Analyst
(174 salaries)
Unlock
₹9.5 L/yr - ₹23 L/yr
Associate Director
(145 salaries)
Unlock
₹30 L/yr - ₹75 L/yr
Data Analyst
(120 salaries)
Unlock
₹4.8 L/yr - ₹17.7 L/yr
Business Analyst
(103 salaries)
Unlock
₹6.3 L/yr - ₹17.9 L/yr
Medical Representative
(98 salaries)
Unlock
₹1.4 L/yr - ₹10.4 L/yr
Financial Analyst
(93 salaries)
Unlock
₹5.8 L/yr - ₹13 L/yr
Senior Specialist
(92 salaries)
Unlock
₹7.5 L/yr - ₹26.2 L/yr
Territory Business Executive
(77 salaries)
Unlock
₹4.8 L/yr - ₹10.3 L/yr
Novartis Interview Questions
Interview questions by designation
Top Novartis interview questions and answers
Get interview-ready with top interview questions
Novartis Jobs
Current Openings
Novartis News
View all
Mizzou Researchers Unveil Innovative Method to Cut Medicine Costs and Promote Sustainable Energy Solutions
- University of Missouri researchers introduce an innovative chemical tool combining micellar water and electrical energy to cut medicine costs and promote sustainable energy solutions.
- The electrochemical technique aims to address the challenge of PFAS, known as 'forever chemicals' posing environmental and health risks.
- Collaborating with Novartis, the team develops micelles from natural amino acids to drive electrochemical reactions efficiently and safely.
- Micelles distinguish themselves by driving reactions and remaining chemically inert, reducing the need for hazardous materials in traditional processes.
- This novel method offers a greener alternative to conventional practices and has potential applications in developing antiviral medications.
- Utilizing micelles in electrochemistry not only aids pharmaceutical synthesis but also advances clean energy technologies by converting water into hydrogen and oxygen.
- The research highlights the dual functionality of micelles and emphasizes their crucial role in clean energy production and environmental stewardship.
- Published in Angewandte Chemie, the study signifies interdisciplinary collaboration and the importance of eco-friendly chemical processes.
- The innovation in micellar electrochemistry stands as a testament to sustainable scientific advancements, aiming to minimize traditional chemical hazards and promote environmental sustainability.
- This pioneering research offers transformative changes in pharmaceuticals, clean energy, and environmental remediation, contributing to a greener and healthier future.
Bioengineer | 4 Mar, 2025
Union Budget 2025: Cancer medicines and patient assistance programmes come in for reprieve
- Medicines from multinational companies, including Pembrolizumab (MSD Pharma), Lorlatinib (Pfizer), Ribociclib (Novartis), Selumetinib (Astra Zeneca), Teclistamab (Johnson & Johnson), Cetuximab (Merck Specialities), Brentuximab Vedotin (Takeda); Mepolizumab (GSK Pharma), Risdiplam Powder (Roche), Luspatercept (Bristol Myers Squibb) are among the 37 listed to get Basic Customs Duty exemptions, provided they are given free.
- Additionally, the budget proposes to add 13 new patient assistance programs for supplying medicines free of cost to patients.
- 36 lifesaving drugs and medicines will be added to the list of medicines fully exempted from Basic Customs Duty (BCD), and 6 lifesaving medicines will be eligible for concessional customs duty of 5 percent.
- The budget also plans to establish 200 daycare cancer centers in all district hospitals in the next three years.
HinduBusinessLine | 1 Feb, 2025
Oss-based biotech company Citryll bags €85M funding to fight inflammatory diseases: Here’s how
- Dutch biotech company Citryll has secured €85M in a Series B funding round.
- The funding will be used to advance the clinical development of CIT-013, a monoclonal antibody targeting Neutrophil Extracellular Traps (NETs).
- Investors in the funding round include Johnson & Johnson, Forbion, Novartis Venture Fund, and others.
- Citryll's NET-targeting approach has potential applications in various immune-mediated inflammatory diseases.
SiliconCanals | 10 Dec, 2024
NEST, an initiative by Novartis, invites students, start-ups and incubators to reimagine medicine
- Novartis Development Hub in India has launched NEST (Nurturing Excellence, Strengthening Talent) to work with Indian medical, healthtech, and pharmaceutical startups, students, and incubators.
- NEST is a case-based competition where participants will solve real-world cases using technology to create solutions for improved clinical development and clinical trial protocols for innovative medicines.
- The program offers a chance to compete for a prize pool of Rs 8 lakh, attend pre-placement interviews at Novartis, and collaborate with expert teams to co-create impactful solutions.
- The program consists of multiple rounds from December 9, 2024, to February 21, 2025, including MCQ Assessment, Screening, Semifinals, Mentorship, and Finals.
Yourstory | 5 Dec, 2024
Aurobindo Pharma wins USFDA approval for generic cancer drug
- Aurobindo Pharma has received approval from the USFDA for its generic cancer drug, bioequivalent to Novartis Pharmaceuticals’ Votrient Tablets.
- The drug is indicated for treating advanced Renal Cell Carcinoma (RCC) and Soft Tissue Sarcoma (STS) in adult patients who have undergone prior chemotherapy.
- The estimated market size for the drug is around US$ 106 million, and Aurobindo plans to launch it in the fourth quarter of fiscal year 2025.
- This approval marks the 179th Abbreviated New Drug Application (ANDA) for Eugia Pharma Specialities Group, the manufacturer of the drug.
HinduBusinessLine | 5 Dec, 2024
Divi's Lab Clarifies After US Court Paves Way For Novartis' Heart Drug Generic; Share Price Down
- Divi's Laboratories' shares fell over 3% as a US court dismissed Novartis AG's bid to block the launch of a generic version of its heart drug Entresto.
- Divi's Labs has a contract manufacturing organisation pact with Novartis for Entresto.
- The launch of the generic drug by MSN Pharmaceuticals is expected to impact the market share of Entresto.
- Divi's Labs clarified that it sees no material impact from this news.
Bloomberg Quint | 5 Dec, 2024
Novartis Raises Sales Guidance Citing Cancer, Inflammatory Drugs
- Novartis AG has raised its medium-term sales target, expecting revenue to grow 6% a year through 2029.
- The company has increased its peak sales estimates for drugs such as Cosentyx, Kisqali, Kesimpta, Pluvicto, and Leqvio.
- Novartis plans to support future growth with more than 15 submission-enabling readouts and over 30 pipeline assets post-2029.
- The company is focused on becoming one of the top five pharmaceutical firms in the US through strategic acquisitions.
Bloomberg Quint | 21 Nov, 2024
Meenakshi Priyam takes charge as CHRO, automotive business, Mahindra Group
- Meenakshi Priyam has been appointed as CHRO, automotive business, Mahindra Group.
- She has previously held leadership positions in companies such as udaan.com, Johnson & Johnson, Novartis, and GSK.
- She is known for her expertise in HR business partnering, compensation, and benefits.
- Meenakshi Priyam is also the Chair-Diversity, Equity, and Inclusion Committee at Bombay Chamber of Commerce and Industry.
HRKatha | 6 Nov, 2024
Powered by
Novartis Subsidiaries
Sandoz
4.0
• 412 reviews
Report error
Compare Novartis with
Dr. Reddy's
4.0
Pfizer
4.0
Biocon Limited
3.9
Aurobindo Pharma
4.0
Lupin
4.2
Zydus Lifesciences
4.1
Torrent Pharmaceuticals
3.9
Intas Pharmaceuticals
4.1
Hetero
3.9
Viatris
4.2
Abbott
4.1
Alkem Laboratories
3.9
Glenmark Pharmaceuticals
3.9
Ipca Laboratories
3.9
MSN Laboratories
3.7
Akums Drugs & Pharmaceuticals Limited
4.4
DIVI'S Laboratories
3.7
Sanofi
4.2
Piramal Group
3.9
Fresenius Kabi
4.2
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Write a review
Share interview
Contribute salary
Add office photos
Companies Similar to Novartis
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.8k reviews
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.8k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.9k reviews
Dr. Reddy's
Clinical Research, Pharma
4.0
• 6.8k reviews
Pfizer
Manufacturing, Pharma
4.0
• 1.8k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.7k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 6k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 6k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.5k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.4k reviews
Hetero
Healthcare / Pharma, Clinical Research, Healthcare, Pharma
3.9
• 3.3k reviews
Novartis FAQs
When was Novartis founded?
Novartis was founded in 1996. The company has been operating for 29 years primarily in the Pharma sector.
Where is the Novartis headquarters located?
Novartis is headquartered in Mumbai, Maharashtra. It operates in 3 cities such as Hyderabad / Secunderabad, Mumbai, Bangalore / Bengaluru. To explore all the office locations, visit Novartis locations.
How many employees does Novartis have in India?
Novartis currently has more than 8,300+ employees in India. Research & Development department appears to have the highest employee count in Novartis based on the number of reviews submitted on AmbitionBox.
Does Novartis have good work-life balance?
Novartis has a work-life balance rating of 4.2 out of 5 based on 1,500+ employee reviews on AmbitionBox. 77% employees rated Novartis 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read Novartis work-life balance reviews for more details
Is Novartis good for career growth?
Career growth at Novartis is rated as moderate, with a promotions and appraisal rating of 3.3. 23% employees rated Novartis 3 or below, while 77% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Novartis promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Novartis?
Working at Novartis comes with several advantages and disadvantages. It is highly rated for work life balance, company culture and salary & benefits. However, it is poorly rated for promotions / appraisal, based on 1,500+ employee reviews on AmbitionBox.
Recently Viewed
LIST OF COMPANIES
NielsenIQ
Overview
LIST OF COMPANIES
Job4sab
Overview
LIST OF COMPANIES
Apexon
Overview
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
